Search Results - mohamed al-shabrawey

1 Results Sort By:
The use of EETs blocker or antagonists to enhance the efficacy of AT1 blocker to treat diabetic retinopathy.
The use of EETs Blocker or Antagonists to Enhance the Efficacy of AT1 blocker to Treat Diabetic RetinopathyApplication: Diabetic Retinopathy (DR)Advantages/Benefits:• This technology in combination with AT1 receptor blockade prevents and reduces DR• This technology can address the 33% of the U.S. population predicted to devel...
Published: 8/8/2018   |   Inventor(s): Mong-Heng Wang, Mohamed Al-Shabrawey
Category(s): Therapeutics
© 2019. All Rights Reserved. Powered by Inteum